To date, 184 clinical studies using BioGaia’s human strains of Lactobacillus reuteri have been performed on 15,500 individuals of all ages. Results have been published in 159 articles in scientific journals (February 2018). Read more
What is Lactobacillus reuteri?
Based on clinical data 100 million CFU per day has been chosen as a safe and efficient dose of Lactobacillus reuteri Protectis for humans. Read more
Baby and child health
The human microbiota, i.e. microorganisms residing in the gastrointestinal tract, is believed to be established directly from birth and during the early years of life. Read more
The balance between good and bad bacteria are believed to be exceptionally important for human health. In a balanced gut, good bacteria outnumber bad ones by ten to one. If bad bacteria start to exceed it may lead to various health conditions such as constipation or diarrhea. Read more
There are more than 700 bacterial species that protect the mouth against bacteria that form plaque and cause gum problems. When the balance among oral bacteria is disrupted due to inadequate oral hygiene, stress and poor diet can plaque forming bacteria gain the upper hand, causing gum problems. Read more
BioGaia collaborates with specialists at around 50 research institutes and clinics in a unique global research network. Many of these researchers are among the foremost in their areas. Read more
BioGaia's probiotic strains
The first strain of Lactobacillus reuteri for human use, L. reuteri DSM 17938, was isolated in 1990.
Lactobacillus reuteri grounded in evolution
Bacteria were the first form of life to “populate” the Earth some four billion years ago, and still today they dictate the conditions for our existence.
BioGaia is an innovative Swedish health care company and a world leader in probiotics with more than 25 years experience of developing, marketing and selling probiotic products.